CANC vs. CNCR ETF Comparison

Comparison of Tema Oncology ETF (CANC) to Loncar Cancer Immunotherapy ETF (CNCR)
CANC

Tema Oncology ETF

CANC Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.62

Average Daily Volume

2,712

Number of Holdings *

43

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.32

Average Daily Volume

3,715

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period CANC CNCR
30 Days -6.65% -10.65%
60 Days -10.02% -14.47%
90 Days -10.36% -9.20%
12 Months 15.15% 30.29%
23 Overlapping Holdings
Symbol Grade Weight in CANC Weight in CNCR Overlap
ACLX C 1.5% 1.73% 1.5%
ARVN F 0.46% 1.39% 0.46%
BCYC F 0.84% 1.24% 0.84%
BNTX D 0.89% 1.25% 0.89%
BPMC C 4.05% 1.58% 1.58%
CGEM F 0.83% 1.2% 0.83%
DAWN D 1.9% 1.44% 1.44%
EXEL B 2.93% 1.9% 1.9%
GMAB F 1.84% 1.17% 1.17%
IDYA F 0.9% 1.07% 0.9%
IMCR C 0.69% 1.42% 0.69%
JANX C 1.43% 1.46% 1.43%
LEGN D 1.41% 1.1% 1.1%
MRK F 2.81% 1.24% 1.24%
MRUS F 1.37% 1.33% 1.33%
NRIX C 1.15% 1.29% 1.15%
NUVL D 1.99% 1.18% 1.18%
RCUS F 0.67% 1.29% 0.67%
REGN F 5.25% 1.0% 1.0%
RLAY F 0.69% 0.91% 0.69%
RVMD B 4.6% 1.84% 1.84%
SDGR C 1.44% 1.39% 1.39%
SWTX C 2.14% 1.47% 1.47%
CANC Overweight 20 Positions Relative to CNCR
Symbol Grade Weight
GILD B 5.49%
ARGX A 4.19%
ILMN C 4.16%
INCY C 4.1%
AGIO C 2.71%
MREO F 2.54%
AMGN D 2.37%
BGNE D 2.3%
CRSP D 2.3%
GH B 2.07%
NVS D 2.03%
NTLA F 1.58%
EXAS D 1.45%
CLDX D 1.44%
LNTH C 1.22%
COGT D 0.95%
ORIC F 0.76%
MRNA F 0.72%
TERN F 0.6%
CGON F 0.56%
CANC Underweight 44 Positions Relative to CNCR
Symbol Grade Weight
GLUE C -2.03%
BMY B -1.72%
ELVN C -1.68%
XNCR B -1.66%
MRSN C -1.62%
KPTI D -1.57%
REPL C -1.56%
GNLX D -1.56%
MGNX D -1.55%
HCM C -1.54%
CRBU D -1.47%
ERAS C -1.46%
RXRX D -1.39%
AURA C -1.38%
LYEL F -1.35%
SNDX F -1.34%
KYMR D -1.32%
RPTX F -1.32%
GERN C -1.31%
IOVA F -1.3%
FHTX C -1.26%
NUVB C -1.26%
ZNTL D -1.25%
YMAB F -1.24%
BMEA F -1.22%
PGEN F -1.2%
ALLO F -1.18%
VOR D -1.17%
TYRA F -1.16%
KURA F -1.16%
ACRV F -1.15%
AUTL F -1.13%
STRO F -1.12%
TSVT F -1.06%
ITOS F -0.98%
IPHA F -0.98%
SMMT D -0.97%
ACET F -0.97%
IMRX F -0.95%
IMTX F -0.93%
IGMS F -0.88%
RAPT F -0.88%
FATE F -0.87%
PRLD F -0.55%
Compare ETFs